ID   PIWL2_MOUSE             Reviewed;         971 AA.
AC   Q8CDG1; A6H617; Q3TQE8; Q99MV6; Q9JMB6;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 2.
DT   07-APR-2021, entry version 137.
DE   RecName: Full=Piwi-like protein 2 {ECO:0000305};
DE            EC=3.1.26.- {ECO:0000269|PubMed:22020280, ECO:0000269|PubMed:23706823, ECO:0000269|PubMed:26669262};
GN   Name=Piwil2 {ECO:0000312|MGI:MGI:1930036};
GN   Synonyms=Mili {ECO:0000303|PubMed:28254886, ECO:0000303|PubMed:28633017};
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, SUBCELLULAR LOCATION,
RP   DEVELOPMENTAL STAGE, AND FUNCTION.
RX   PubMed=11578866; DOI=10.1016/s0925-4773(01)00499-3;
RA   Kuramochi-Miyagawa S.K., Kimura T., Yomogida K., Kuroiwa A., Tadokoro Y.,
RA   Fujita Y., Sato M., Matsuda Y., Nakano T.;
RT   "Two mouse piwi-related genes: miwi and mili.";
RL   Mech. Dev. 108:121-133(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Medulla oblongata, and Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J.,
RA   Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R.,
RA   Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T.,
RA   Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A.,
RA   Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B.,
RA   Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M.,
RA   Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S.,
RA   Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D.,
RA   Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M.,
RA   Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H.,
RA   Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V.,
RA   Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S.,
RA   Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H.,
RA   Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N.,
RA   Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F.,
RA   Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G.,
RA   Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z.,
RA   Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S.,
RA   Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K.,
RA   Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R.,
RA   van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H.,
RA   Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M.,
RA   Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C.,
RA   Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S.,
RA   Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K.,
RA   Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M.,
RA   Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C.,
RA   Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A.,
RA   Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 359-971, AND TISSUE SPECIFICITY.
RC   TISSUE=Testis;
RX   PubMed=11279525; DOI=10.1038/86927;
RA   Wang P.J., McCarrey J.R., Yang F., Page D.C.;
RT   "An abundance of X-linked genes expressed in spermatogonia.";
RL   Nat. Genet. 27:422-426(2001).
RN   [6]
RP   TISSUE SPECIFICITY.
RX   PubMed=12906857; DOI=10.1016/s0888-7543(03)00129-0;
RA   Sasaki T., Shiohama A., Minoshima S., Shimizu N.;
RT   "Identification of eight members of the Argonaute family in the human
RT   genome.";
RL   Genomics 82:323-330(2003).
RN   [7]
RP   FUNCTION, INTERACTION WITH DDX4, AND DISRUPTION PHENOTYPE.
RX   PubMed=14736746; DOI=10.1242/dev.00973;
RA   Kuramochi-Miyagawa S., Kimura T., Ijiri T.W., Isobe T., Asada N.,
RA   Fujita Y., Ikawa M., Iwai N., Okabe M., Deng W., Lin H., Matsuda Y.,
RA   Nakano T.;
RT   "Mili, a mammalian member of piwi family gene, is essential for
RT   spermatogenesis.";
RL   Development 131:839-849(2004).
RN   [8]
RP   FUNCTION.
RX   PubMed=16261612; DOI=10.1002/mrd.20391;
RA   Lee J.H., Engel W., Nayernia K.;
RT   "Stem cell protein Piwil2 modulates expression of murine spermatogonial
RT   stem cell expressed genes.";
RL   Mol. Reprod. Dev. 73:173-179(2006).
RN   [9]
RP   RNA-BINDING.
RX   PubMed=16751777; DOI=10.1038/nature04916;
RA   Aravin A., Gaidatzis D., Pfeffer S., Lagos-Quintana M., Landgraf P.,
RA   Iovino N., Morris P., Brownstein M.J., Kuramochi-Miyagawa S., Nakano T.,
RA   Chien M., Russo J.J., Ju J., Sheridan R., Sander C., Zavolan M., Tuschl T.;
RT   "A novel class of small RNAs bind to MILI protein in mouse testes.";
RL   Nature 442:203-207(2006).
RN   [10]
RP   INTERACTION WITH MAEL.
RX   PubMed=16787967; DOI=10.1093/hmg/ddl158;
RA   Costa Y., Speed R.M., Gautier P., Semple C.A., Maratou K., Turner J.M.A.,
RA   Cooke H.J.;
RT   "Mouse MAELSTROM: the link between meiotic silencing of unsynapsed
RT   chromatin and microRNA pathway?";
RL   Hum. Mol. Genet. 15:2324-2334(2006).
RN   [11]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=17446352; DOI=10.1126/science.1142612;
RA   Aravin A.A., Sachidanandam R., Girard A., Fejes-Toth K., Hannon G.J.;
RT   "Developmentally regulated piRNA clusters implicate MILI in transposon
RT   control.";
RL   Science 316:744-747(2007).
RN   [12]
RP   FUNCTION, AND DISRUPTION PHENOTYPE.
RX   PubMed=18381894; DOI=10.1101/gad.1640708;
RA   Kuramochi-Miyagawa S., Watanabe T., Gotoh K., Totoki Y., Toyoda A.,
RA   Ikawa M., Asada N., Kojima K., Yamaguchi Y., Ijiri T.W., Hata K., Li E.,
RA   Matsuda Y., Kimura T., Okabe M., Sakaki Y., Sasaki H., Nakano T.;
RT   "DNA methylation of retrotransposon genes is regulated by Piwi family
RT   members MILI and MIWI2 in murine fetal testes.";
RL   Genes Dev. 22:908-917(2008).
RN   [13]
RP   RNA-BINDING, AND TISSUE SPECIFICITY.
RX   PubMed=18404146; DOI=10.1038/nature06908;
RA   Watanabe T., Totoki Y., Toyoda A., Kaneda M., Kuramochi-Miyagawa S.,
RA   Obata Y., Chiba H., Kohara Y., Kono T., Nakano T., Surani M.A., Sakaki Y.,
RA   Sasaki H.;
RT   "Endogenous siRNAs from naturally formed dsRNAs regulate transcripts in
RT   mouse oocytes.";
RL   Nature 453:539-543(2008).
RN   [14]
RP   FUNCTION, RNA-BINDING, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=18922463; DOI=10.1016/j.molcel.2008.09.003;
RA   Aravin A.A., Sachidanandam R., Bourc'his D., Schaefer C., Pezic D.,
RA   Toth K.F., Bestor T., Hannon G.J.;
RT   "A piRNA pathway primed by individual transposons is linked to de novo DNA
RT   methylation in mice.";
RL   Mol. Cell 31:785-799(2008).
RN   [15]
RP   INTERACTION WITH TDRD1.
RX   PubMed=19345100; DOI=10.1016/j.cub.2009.02.061;
RA   Wang J., Saxe J.P., Tanaka T., Chuma S., Lin H.;
RT   "Mili interacts with tudor domain-containing protein 1 in regulating
RT   spermatogenesis.";
RL   Curr. Biol. 19:640-644(2009).
RN   [16]
RP   METHYLATION AT ARG-74; ARG-95; ARG-100; ARG-163 AND ARG-549, SUBCELLULAR
RP   LOCATION, INTERACTION WITH TDRD1; PRMT5 AND WDR77, AND MUTAGENESIS OF
RP   ARG-9; ARG-39; ARG-45 AND ARG-74.
RX   PubMed=19584108; DOI=10.1101/gad.1814809;
RA   Vagin V.V., Wohlschlegel J., Qu J., Jonsson Z., Huang X., Chuma S.,
RA   Girard A., Sachidanandam R., Hannon G.J., Aravin A.A.;
RT   "Proteomic analysis of murine Piwi proteins reveals a role for arginine
RT   methylation in specifying interaction with Tudor family members.";
RL   Genes Dev. 23:1749-1762(2009).
RN   [17]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INTERACTION WITH
RP   EIF3A; EIF4E AND EIF4G.
RX   PubMed=19114715; DOI=10.1074/jbc.m809104200;
RA   Unhavaithaya Y., Hao Y., Beyret E., Yin H., Kuramochi-Miyagawa S.,
RA   Nakano T., Lin H.;
RT   "MILI, a PIWI-interacting RNA-binding protein, is required for germ Line
RT   stem cell self-renewal and appears to positively regulate translation.";
RL   J. Biol. Chem. 284:6507-6519(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY, TISSUE SPECIFICITY, AND METHYLATION.
RX   PubMed=19377467; DOI=10.1038/ncb1872;
RA   Kirino Y., Kim N., de Planell-Saguer M., Khandros E., Chiorean S.,
RA   Klein P.S., Rigoutsos I., Jongens T.A., Mourelatos Z.;
RT   "Arginine methylation of Piwi proteins catalysed by dPRMT5 is required for
RT   Ago3 and Aub stability.";
RL   Nat. Cell Biol. 11:652-658(2009).
RN   [19]
RP   METHYLATION AT ARG-74, SUBCELLULAR LOCATION, AND INTERACTION WITH TDRD1.
RX   PubMed=19465913; DOI=10.1038/nsmb.1615;
RA   Reuter M., Chuma S., Tanaka T., Franz T., Stark A., Pillai R.S.;
RT   "Loss of the Mili-interacting Tudor domain-containing protein-1 activates
RT   transposons and alters the Mili-associated small RNA profile.";
RL   Nat. Struct. Mol. Biol. 16:639-646(2009).
RN   [20]
RP   METHYLATION AT ARG-45; ARG-74; ARG-83; ARG-95; ARG-100; ARG-144; ARG-156
RP   AND ARG-163, AND INTERACTION WITH TDRKH.
RX   PubMed=19918066; DOI=10.1073/pnas.0911640106;
RA   Chen C., Jin J., James D.A., Adams-Cioaba M.A., Park J.G., Guo Y.,
RA   Tenaglia E., Xu C., Gish G., Min J., Pawson T.;
RT   "Mouse Piwi interactome identifies binding mechanism of Tdrkh Tudor domain
RT   to arginine methylated Miwi.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:20336-20341(2009).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Testis;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [22]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20439430; DOI=10.1101/gad.1902110;
RA   Kuramochi-Miyagawa S., Watanabe T., Gotoh K., Takamatsu K., Chuma S.,
RA   Kojima-Kita K., Shiromoto Y., Asada N., Toyoda A., Fujiyama A., Totoki Y.,
RA   Shibata T., Kimura T., Nakatsuji N., Noce T., Sasaki H., Nakano T.;
RT   "MVH in piRNA processing and gene silencing of retrotransposons.";
RL   Genes Dev. 24:887-892(2010).
RN   [23]
RP   INTERACTION WITH MOV10L1.
RX   PubMed=20534472; DOI=10.1073/pnas.1003953107;
RA   Zheng K., Xiol J., Reuter M., Eckardt S., Leu N.A., McLaughlin K.J.,
RA   Stark A., Sachidanandam R., Pillai R.S., Wang P.J.;
RT   "Mouse MOV10L1 associates with Piwi proteins and is an essential component
RT   of the Piwi-interacting RNA (piRNA) pathway.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:11841-11846(2010).
RN   [24]
RP   INTERACTION WITH MOV10L1.
RX   PubMed=20547853; DOI=10.1073/pnas.1007158107;
RA   Frost R.J., Hamra F.K., Richardson J.A., Qi X., Bassel-Duby R., Olson E.N.;
RT   "MOV10L1 is necessary for protection of spermatocytes against
RT   retrotransposons by Piwi-interacting RNAs.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:11847-11852(2010).
RN   [25]
RP   FUNCTION, AND MUTAGENESIS OF ASP-813.
RX   PubMed=22020280; DOI=10.1038/nature10547;
RA   De Fazio S., Bartonicek N., Di Giacomo M., Abreu-Goodger C., Sankar A.,
RA   Funaya C., Antony C., Moreira P.N., Enright A.J., O'Carroll D.;
RT   "The endonuclease activity of Mili fuels piRNA amplification that silences
RT   LINE1 elements.";
RL   Nature 480:259-263(2011).
RN   [26]
RP   INTERACTION WITH TDRD12.
RX   PubMed=24067652; DOI=10.1073/pnas.1316316110;
RA   Pandey R.R., Tokuzawa Y., Yang Z., Hayashi E., Ichisaka T., Kajita S.,
RA   Asano Y., Kunieda T., Sachidanandam R., Chuma S., Yamanaka S., Pillai R.S.;
RT   "Tudor domain containing 12 (TDRD12) is essential for secondary PIWI
RT   interacting RNA biogenesis in mice.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:16492-16497(2013).
RN   [27]
RP   FUNCTION, TISSUE SPECIFICITY, AND MUTAGENESIS OF ASP-813.
RX   PubMed=23706823; DOI=10.1016/j.molcel.2013.04.026;
RA   Di Giacomo M., Comazzetto S., Saini H., De Fazio S., Carrieri C.,
RA   Morgan M., Vasiliauskaite L., Benes V., Enright A.J., O'Carroll D.;
RT   "Multiple epigenetic mechanisms and the piRNA pathway enforce LINE1
RT   silencing during adult spermatogenesis.";
RL   Mol. Cell 50:601-608(2013).
RN   [28]
RP   INTERACTION WITH GPAT2.
RX   PubMed=23611983; DOI=10.1261/rna.038521.113;
RA   Shiromoto Y., Kuramochi-Miyagawa S., Daiba A., Chuma S., Katanaya A.,
RA   Katsumata A., Nishimura K., Ohtaka M., Nakanishi M., Nakamura T.,
RA   Yoshinaga K., Asada N., Nakamura S., Yasunaga T., Kojima-Kita K., Itou D.,
RA   Kimura T., Nakano T.;
RT   "GPAT2, a mitochondrial outer membrane protein, in piRNA biogenesis in
RT   germline stem cells.";
RL   RNA 19:803-810(2013).
RN   [29]
RP   FUNCTION, AND IDENTIFICATION IN THE PET COMPLEX.
RX   PubMed=26669262; DOI=10.1016/j.molcel.2015.11.009;
RA   Yang Z., Chen K.M., Pandey R.R., Homolka D., Reuter M., Janeiro B.K.,
RA   Sachidanandam R., Fauvarque M.O., McCarthy A.A., Pillai R.S.;
RT   "PIWI slicing and EXD1 drive biogenesis of nuclear piRNAs from cytosolic
RT   targets of the mouse piRNA pathway.";
RL   Mol. Cell 61:138-152(2016).
RN   [30]
RP   FUNCTION.
RX   PubMed=28633017; DOI=10.1016/j.devcel.2017.05.021;
RA   Wenda J.M., Homolka D., Yang Z., Spinelli P., Sachidanandam R.,
RA   Pandey R.R., Pillai R.S.;
RT   "Distinct roles of RNA helicases MVH and TDRD9 in PIWI slicing-triggered
RT   mammalian piRNA biogenesis and function.";
RL   Dev. Cell 41:623-637(2017).
RN   [31]
RP   INTERACTION WITH TEX19.1.
RX   PubMed=28254886; DOI=10.1242/jcs.188763;
RA   Tarabay Y., Achour M., Teletin M., Ye T., Teissandier A., Mark M.,
RA   Bourc'his D., Viville S.;
RT   "Tex19 paralogs are new members of the piRNA pathway controlling
RT   retrotransposon suppression.";
RL   J. Cell Sci. 130:1463-1474(2017).
RN   [32]
RP   FUNCTION, INTERACTION WITH ARNTL; CLOCK AND GSK3B, AND TISSUE SPECIFICITY.
RX   PubMed=28903391; DOI=10.18632/oncotarget.18973;
RA   Lu Y., Zheng X., Hu W., Bian S., Zhang Z., Tao D., Liu Y., Ma Y.;
RT   "Cancer/testis antigen PIWIL2 suppresses circadian rhythms by regulating
RT   the stability and activity of BMAL1 and CLOCK.";
RL   Oncotarget 8:54913-54924(2017).
RN   [33]
RP   INTERACTION WITH TEX15, SUBCELLULAR LOCATION, AND DEVELOPMENTAL STAGE.
RX   PubMed=32381626; DOI=10.1101/gad.335489.119;
RA   Yang F., Lan Y., Pandey R.R., Homolka D., Berger S.L., Pillai R.S.,
RA   Bartolomei M.S., Wang P.J.;
RT   "TEX15 associates with MILI and silences transposable elements in male germ
RT   cells.";
RL   Genes Dev. 34:745-750(2020).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) OF 38-50 IN COMPLEX WITH TDRD1,
RP   SUBUNIT, AND METHYLATION AT ARG-45 AND ARG-74.
RX   PubMed=22996915; DOI=10.1261/rna.034181.112;
RA   Mathioudakis N., Palencia A., Kadlec J., Round A., Tripsianes K.,
RA   Sattler M., Pillai R.S., Cusack S.;
RT   "The multiple Tudor domain-containing protein TDRD1 is a molecular scaffold
RT   for mouse Piwi proteins and piRNA biogenesis factors.";
RL   RNA 18:2056-2072(2012).
CC   -!- FUNCTION: Endoribonuclease that plays a central role during
CC       spermatogenesis by repressing transposable elements and preventing
CC       their mobilization, which is essential for the germline integrity
CC       (PubMed:11578866, PubMed:14736746, PubMed:17446352, PubMed:18381894,
CC       PubMed:18922463, PubMed:26669262). Plays an essential role in meiotic
CC       differentiation of spermatocytes, germ cell differentiation and in
CC       self-renewal of spermatogonial stem cells (PubMed:11578866,
CC       PubMed:14736746, PubMed:17446352, PubMed:18381894, PubMed:18922463,
CC       PubMed:26669262). Its presence in oocytes suggests that it may
CC       participate in similar functions during oogenesis in females
CC       (PubMed:11578866, PubMed:14736746, PubMed:17446352, PubMed:18381894,
CC       PubMed:18922463, PubMed:26669262). Acts via the piRNA metabolic
CC       process, which mediates the repression of transposable elements during
CC       meiosis by forming complexes composed of piRNAs and Piwi proteins and
CC       govern the methylation and subsequent repression of transposons
CC       (PubMed:11578866, PubMed:14736746, PubMed:17446352, PubMed:18381894,
CC       PubMed:18922463, PubMed:26669262). During piRNA biosynthesis, plays a
CC       key role in the piRNA amplification loop, also named ping-pong
CC       amplification cycle, by acting as a 'slicer-competent' piRNA
CC       endoribonuclease that cleaves primary piRNAs, which are then loaded
CC       onto 'slicer-incompetent' PIWIL4 (PubMed:22020280, PubMed:23706823,
CC       PubMed:26669262). PIWIL2 slicing produces a pre-miRNA intermediate,
CC       which is then processed in mature piRNAs, and as well as a 16
CC       nucleotide by-product that is degraded (PubMed:28633017). Required for
CC       PIWIL4/MIWI2 nuclear localization and association with secondary piRNAs
CC       antisense (PubMed:18381894, PubMed:18922463, PubMed:26669262). Besides
CC       their function in transposable elements repression, piRNAs are probably
CC       involved in other processes during meiosis such as translation
CC       regulation (PubMed:19114715). Indirectly modulates expression of genes
CC       such as PDGFRB, SLC2A1, ITGA6, GJA7, THY1, CD9 and STRA8
CC       (PubMed:16261612). Represses circadian rhythms by promoting the
CC       stability and activity of core clock components ARNTL/BMAL1 and CLOCK
CC       by inhibiting GSK3B-mediated phosphorylation and ubiquitination-
CC       dependent degradation of these proteins (PubMed:28903391).
CC       {ECO:0000269|PubMed:11578866, ECO:0000269|PubMed:14736746,
CC       ECO:0000269|PubMed:16261612, ECO:0000269|PubMed:17446352,
CC       ECO:0000269|PubMed:18381894, ECO:0000269|PubMed:18922463,
CC       ECO:0000269|PubMed:19114715, ECO:0000269|PubMed:22020280,
CC       ECO:0000269|PubMed:23706823, ECO:0000269|PubMed:26669262,
CC       ECO:0000269|PubMed:28633017, ECO:0000269|PubMed:28903391}.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC         Evidence={ECO:0000250|UniProtKB:Q9JMB7};
CC   -!- SUBUNIT: Interacts with DDX4, MAEL, EIF3A, EIF4E, EIF4G, PRMT5 and
CC       WDR77. Associates with EIF4E- and EIF4G-containing m7G cap-binding
CC       complexes. Interacts (when methylated on arginine residues) with TDRD1
CC       and TDRKH/TDRD2. Interacts with TDRD12 (PubMed:24067652). Component of
CC       the PET complex, at least composed of EXD1, PIWIL2, TDRD12 and piRNAs
CC       (PubMed:26669262). Interacts with MOV10L1 (PubMed:20534472,
CC       PubMed:20547853). Interacts with GPAT2 (PubMed:23611983). Interacts
CC       with Tex19.1 and, probably, Tex19.2 (PubMed:28254886). Interacts (via
CC       PIWI domain) with ARNTL/BMAL1 and CLOCK (PubMed:28903391). Interacts
CC       with GSK3B (PubMed:28903391). Interacts with TEX15 (PubMed:32381626).
CC       {ECO:0000269|PubMed:14736746, ECO:0000269|PubMed:16787967,
CC       ECO:0000269|PubMed:19114715, ECO:0000269|PubMed:19345100,
CC       ECO:0000269|PubMed:19465913, ECO:0000269|PubMed:19584108,
CC       ECO:0000269|PubMed:19918066, ECO:0000269|PubMed:20534472,
CC       ECO:0000269|PubMed:20547853, ECO:0000269|PubMed:22996915,
CC       ECO:0000269|PubMed:23611983, ECO:0000269|PubMed:24067652,
CC       ECO:0000269|PubMed:26669262, ECO:0000269|PubMed:28254886,
CC       ECO:0000269|PubMed:28903391, ECO:0000269|PubMed:32381626}.
CC   -!- INTERACTION:
CC       Q8CDG1; Q99MV1: Tdrd1; NbExp=6; IntAct=EBI-8573412, EBI-8573364;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11578866,
CC       ECO:0000269|PubMed:18922463, ECO:0000269|PubMed:19114715,
CC       ECO:0000269|PubMed:19465913, ECO:0000269|PubMed:19584108,
CC       ECO:0000269|PubMed:20439430, ECO:0000269|PubMed:32381626}. Note=Present
CC       in chromatoid body. Probable component of the meiotic nuage, also named
CC       P granule, a germ-cell-specific organelle required to repress
CC       transposon activity during meiosis (PubMed:20439430).
CC       {ECO:0000269|PubMed:20439430}.
CC   -!- TISSUE SPECIFICITY: Expressed in adult testis, specifically in
CC       spermatocytes and in spermatogonia (PubMed:11279525, PubMed:11578866,
CC       PubMed:12906857, PubMed:18404146, PubMed:18922463, PubMed:19114715,
CC       PubMed:19377467, PubMed:28903391). Only detected in primordial germ
CC       cells of both sexes. Widely expressed in tumors. Also present at early
CC       stages of oocyte growth. Present in the mitotic spermatogonia
CC       (PubMed:23706823). Not detected in the first stages of meiosis
CC       (preleptotene and leptotene) (PubMed:23706823). Detected at the late
CC       zygotene stage and increases throughout pachytene, declining from this
CC       stage onward until expression stops at the early round spermatid stage
CC       (at protein level) (PubMed:23706823). {ECO:0000269|PubMed:11279525,
CC       ECO:0000269|PubMed:11578866, ECO:0000269|PubMed:12906857,
CC       ECO:0000269|PubMed:18404146, ECO:0000269|PubMed:18922463,
CC       ECO:0000269|PubMed:19114715, ECO:0000269|PubMed:19377467,
CC       ECO:0000269|PubMed:23706823, ECO:0000269|PubMed:28903391}.
CC   -!- DEVELOPMENTAL STAGE: Expressed from 12.5 dpc until adult in male
CC       gonads. In female gonads, detected since 12.5 dpc, then begins to cease
CC       after birth and disappears until the development of adult ovary
CC       (PubMed:11578866). Highly expressed in embryonic male germ cells at
CC       embryonic day 16.5 and expression decreases by postnatal day 2.5
CC       (PubMed:32381626). {ECO:0000269|PubMed:11578866,
CC       ECO:0000269|PubMed:32381626}.
CC   -!- PTM: Arginine methylation by PRMT5 is required for the interaction with
CC       Tudor domain-containing protein TDRD1 and subsequent localization to
CC       the meiotic nuage, also named P granule. {ECO:0000269|PubMed:19377467,
CC       ECO:0000269|PubMed:19465913, ECO:0000269|PubMed:19584108,
CC       ECO:0000269|PubMed:19918066, ECO:0000269|PubMed:22996915}.
CC   -!- DISRUPTION PHENOTYPE: Mice exhibit blocked spermatogenesis at the early
CC       prophase of the first meiosis due to transposable elements
CC       derepression, and apoptosis occurs subsequently. Female mice are
CC       fertile, while male are sterile. {ECO:0000269|PubMed:14736746,
CC       ECO:0000269|PubMed:17446352, ECO:0000269|PubMed:18381894}.
CC   -!- SIMILARITY: Belongs to the argonaute family. Piwi subfamily.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAK31965.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB032605; BAA93706.1; -; mRNA.
DR   EMBL; AK030116; BAC26791.1; -; mRNA.
DR   EMBL; AK163647; BAE37436.1; -; mRNA.
DR   EMBL; CH466535; EDL35904.1; -; Genomic_DNA.
DR   EMBL; BC138444; AAI38445.1; -; mRNA.
DR   EMBL; BC145717; AAI45718.1; -; mRNA.
DR   EMBL; AF285586; AAK31965.1; ALT_INIT; mRNA.
DR   CCDS; CCDS27252.1; -.
DR   RefSeq; NP_067283.1; NM_021308.1.
DR   RefSeq; XP_006519392.1; XM_006519329.3.
DR   PDB; 4B9W; X-ray; 2.10 A; P/S=38-50.
DR   PDBsum; 4B9W; -.
DR   SMR; Q8CDG1; -.
DR   BioGRID; 208309; 4.
DR   CORUM; Q8CDG1; -.
DR   DIP; DIP-48522N; -.
DR   IntAct; Q8CDG1; 4.
DR   MINT; Q8CDG1; -.
DR   STRING; 10090.ENSMUSP00000047385; -.
DR   iPTMnet; Q8CDG1; -.
DR   PhosphoSitePlus; Q8CDG1; -.
DR   PaxDb; Q8CDG1; -.
DR   PRIDE; Q8CDG1; -.
DR   ProteomicsDB; 288175; -.
DR   Antibodypedia; 22585; 252 antibodies.
DR   Ensembl; ENSMUST00000048129; ENSMUSP00000047385; ENSMUSG00000033644.
DR   GeneID; 57746; -.
DR   KEGG; mmu:57746; -.
DR   UCSC; uc007unx.1; mouse.
DR   CTD; 55124; -.
DR   MGI; MGI:1930036; Piwil2.
DR   eggNOG; KOG1042; Eukaryota.
DR   GeneTree; ENSGT00950000183200; -.
DR   HOGENOM; CLU_008813_0_0_1; -.
DR   InParanoid; Q8CDG1; -.
DR   OMA; NYHPKMV; -.
DR   OrthoDB; 220258at2759; -.
DR   PhylomeDB; Q8CDG1; -.
DR   TreeFam; TF354206; -.
DR   BioGRID-ORCS; 57746; 0 hits in 54 CRISPR screens.
DR   ChiTaRS; Piwil2; mouse.
DR   PRO; PR:Q8CDG1; -.
DR   Proteomes; UP000000589; Chromosome 14.
DR   RNAct; Q8CDG1; protein.
DR   Bgee; ENSMUSG00000033644; Expressed in spermatocyte and 121 other tissues.
DR   ExpressionAtlas; Q8CDG1; baseline and differential.
DR   Genevisible; Q8CDG1; MM.
DR   GO; GO:0033391; C:chromatoid body; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0097433; C:dense body; IDA:MGI.
DR   GO; GO:0005634; C:nucleus; IDA:MGI.
DR   GO; GO:0043186; C:P granule; IDA:UniProtKB.
DR   GO; GO:0010370; C:perinucleolar chromocenter; IDA:MGI.
DR   GO; GO:1990923; C:PET complex; IDA:UniProtKB.
DR   GO; GO:0071546; C:pi-body; IDA:UniProtKB.
DR   GO; GO:0004521; F:endoribonuclease activity; IDA:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003729; F:mRNA binding; IDA:UniProtKB.
DR   GO; GO:0034584; F:piRNA binding; IDA:UniProtKB.
DR   GO; GO:1905538; F:polysome binding; IDA:UniProtKB.
DR   GO; GO:0043046; P:DNA methylation involved in gamete generation; IMP:UniProtKB.
DR   GO; GO:0031047; P:gene silencing by RNA; IMP:UniProtKB.
DR   GO; GO:0030718; P:germ-line stem cell population maintenance; IMP:UniProtKB.
DR   GO; GO:0051321; P:meiotic cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; IMP:UniProtKB.
DR   GO; GO:0010529; P:negative regulation of transposition; IMP:UniProtKB.
DR   GO; GO:0048477; P:oogenesis; IEP:UniProtKB.
DR   GO; GO:1990511; P:piRNA biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0034587; P:piRNA metabolic process; IDA:UniProtKB.
DR   GO; GO:0071442; P:positive regulation of histone H3-K14 acetylation; IMP:CACAO.
DR   GO; GO:2000617; P:positive regulation of histone H3-K9 acetylation; IDA:CACAO.
DR   GO; GO:0060903; P:positive regulation of meiosis I; IMP:MGI.
DR   GO; GO:0045727; P:positive regulation of translation; IMP:UniProtKB.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0000966; P:RNA 5'-end processing; IDA:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IMP:UniProtKB.
DR   Gene3D; 3.30.420.10; -; 1.
DR   InterPro; IPR014811; ArgoL1.
DR   InterPro; IPR003100; PAZ_dom.
DR   InterPro; IPR036085; PAZ_dom_sf.
DR   InterPro; IPR003165; Piwi.
DR   InterPro; IPR012337; RNaseH-like_sf.
DR   InterPro; IPR036397; RNaseH_sf.
DR   Pfam; PF08699; ArgoL1; 1.
DR   Pfam; PF02170; PAZ; 1.
DR   Pfam; PF02171; Piwi; 1.
DR   SMART; SM01163; DUF1785; 1.
DR   SMART; SM00949; PAZ; 1.
DR   SMART; SM00950; Piwi; 1.
DR   SUPFAM; SSF101690; SSF101690; 1.
DR   SUPFAM; SSF53098; SSF53098; 1.
DR   PROSITE; PS50821; PAZ; 1.
DR   PROSITE; PS50822; PIWI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Biological rhythms; Cytoplasm; Developmental protein;
KW   Differentiation; Endonuclease; Hydrolase; Meiosis; Metal-binding;
KW   Methylation; Nuclease; Oogenesis; Reference proteome; RNA-binding;
KW   RNA-mediated gene silencing; Spermatogenesis; Translation regulation.
FT   CHAIN           1..971
FT                   /note="Piwi-like protein 2"
FT                   /id="PRO_0000234570"
FT   DOMAIN          386..494
FT                   /note="PAZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00142"
FT   DOMAIN          666..957
FT                   /note="Piwi"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00150"
FT   ACT_SITE        743
FT                   /evidence="ECO:0000250|UniProtKB:A8D8P8"
FT   ACT_SITE        781
FT                   /evidence="ECO:0000250|UniProtKB:A8D8P8"
FT   ACT_SITE        813
FT                   /evidence="ECO:0000250|UniProtKB:A8D8P8"
FT   ACT_SITE        946
FT                   /evidence="ECO:0000250|UniProtKB:A8D8P8"
FT   MOD_RES         45
FT                   /note="Symmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:19918066,
FT                   ECO:0000269|PubMed:22996915"
FT   MOD_RES         74
FT                   /note="Omega-N-methylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000269|PubMed:19465913,
FT                   ECO:0000269|PubMed:19584108, ECO:0000269|PubMed:19918066,
FT                   ECO:0000269|PubMed:22996915"
FT   MOD_RES         74
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000269|PubMed:19465913,
FT                   ECO:0000269|PubMed:19584108, ECO:0000269|PubMed:19918066,
FT                   ECO:0000269|PubMed:22996915"
FT   MOD_RES         83
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19918066"
FT   MOD_RES         83
FT                   /note="Symmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000305|PubMed:19918066"
FT   MOD_RES         95
FT                   /note="Omega-N-methylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000269|PubMed:19584108,
FT                   ECO:0000269|PubMed:19918066"
FT   MOD_RES         95
FT                   /note="Symmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19584108,
FT                   ECO:0000269|PubMed:19918066"
FT   MOD_RES         100
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:19584108,
FT                   ECO:0000269|PubMed:19918066"
FT   MOD_RES         100
FT                   /note="Symmetric dimethylarginine; by PRMT5; alternate"
FT                   /evidence="ECO:0000269|PubMed:19584108,
FT                   ECO:0000269|PubMed:19918066"
FT   MOD_RES         144
FT                   /note="Symmetric dimethylarginine"
FT                   /evidence="ECO:0000305|PubMed:19918066"
FT   MOD_RES         156
FT                   /note="Symmetric dimethylarginine"
FT                   /evidence="ECO:0000305|PubMed:19918066"
FT   MOD_RES         163
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000269|PubMed:19584108,
FT                   ECO:0000269|PubMed:19918066"
FT   MOD_RES         549
FT                   /note="Symmetric dimethylarginine; by PRMT5"
FT                   /evidence="ECO:0000269|PubMed:19584108"
FT   MUTAGEN         9
FT                   /note="R->K: Abolishes interaction with TDRD1; when
FT                   associated with K-39; K-45 and K-74."
FT                   /evidence="ECO:0000269|PubMed:19584108"
FT   MUTAGEN         39
FT                   /note="R->K: Abolishes interaction with TDRD1; when
FT                   associated with K-9; K-45 and K-74."
FT                   /evidence="ECO:0000269|PubMed:19584108"
FT   MUTAGEN         45
FT                   /note="R->K: Abolishes interaction with TDRD1; when
FT                   associated with K-9; K-39 and K-74."
FT                   /evidence="ECO:0000269|PubMed:19584108"
FT   MUTAGEN         74
FT                   /note="R->K: Abolishes interaction with TDRD1; when
FT                   associated with K-9; K-39 and K-45."
FT                   /evidence="ECO:0000269|PubMed:19584108"
FT   MUTAGEN         813
FT                   /note="D->A: In DAH mutant; leads to arrest in meiotic
FT                   prophase due to a failure of transposon piRNA
FT                   amplification, resulting in the marked reduction of piRNA-
FT                   bound within PIWIL4."
FT                   /evidence="ECO:0000269|PubMed:22020280,
FT                   ECO:0000269|PubMed:23706823"
FT   CONFLICT        517
FT                   /note="Q -> E (in Ref. 2; BAE37436)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        542
FT                   /note="T -> A (in Ref. 2; BAC26791)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        583
FT                   /note="D -> G (in Ref. 5; AAK31965)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        634
FT                   /note="I -> T (in Ref. 5; AAK31965)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   971 AA;  109488 MW;  01E143C6513310FB CRC64;
     MDPVRPLFRG PTPVHPSQCV RMPGCWPQAP RPLEPAWGRA GPAGRGLVFR KPEDSSPPLQ
     PVQKDSVGLV SMFRGMGLDT AFRPPSKREV PPLGRGVLGR GLSANMVRKD REEPRSSLPD
     PSVLAAGDSK LAEASVGWSR MLGRGSSEVS LLPLGRAASS IGRGMDKPPS AFGLTARDPP
     RLPQPPALSP TSLHSADPPP VLTMERKEKE LLVKQGSKGT PQSLGLNLIK IQCHNEAVYQ
     YHVTFSPSVE CKSMRFGMLK DHQSVTGNVT AFDGSILYLP VKLQQVVELK SQRKTDDAEI
     SIKIQLTKIL EPCSDLCIPF YNVVFRRVMK LLDMKLVGRN FYDPTSAMVL QQHRLQIWPG
     YAASIRRTDG GLFLLADVSH KVIRNDSVLD VMHAIYQQNK EHFQDECSKL LVGSIVITRY
     NNRTYRIDDV DWNKTPKDSF VMSDGKEITF LEYYSKNYGI TVKEDDQPLL IHRPSERQNN
     HGMLLKGEIL LLPELSFMTG IPEKMKKDFR AMKDLTQQIN LSPKQHHGAL ECLLQRISQN
     ETASNELTRW GLSLHKDVHK IEGRLLPMER INLRNTSFVT SEDLNWVKEV TRDASILTIP
     MHFWALFYPK RAMDQARELV NMLEKIAGPI GMRISPPAWV ELKDDRIETY IRTIQSLLGV
     EGKIQMVVCI IMGTRDDLYG AIKKLCCVQS PVPSQVINVR TIGQPTRLRS VAQKILLQMN
     CKLGGELWGV DIPLKQLMVI GMDVYHDPSR GMRSVVGFVA SINLTLTKWY SRVVFQMPHQ
     EIVDSLKLCL VGSLKKYYEV NHCLPEKIVV YRDGVSDGQL KTVANYEIPQ LQKCFEAFDN
     YHPKMVVFVV QKKISTNLYL AAPDHFVTPS PGTVVDHTIT SCEWVDFYLL AHHVRQGCGI
     PTHYICVLNT ANLSPDHMQR LTFKLCHMYW NWPGTIRVPA PCKYAHKLAF LSGQILHHEP
     AIQLCGNLFF L
//
